Browse > Article
http://dx.doi.org/10.4014/mbl.1509.09002

Anti-Obesity Activity of Euptelea Pleiosperma Ethanol Extract  

Park, Jung Ae (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Jin, Kyong-Suk (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Kwon, Hyun Ju (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Kim, Byung Woo (Blue-Bio Industry Regional Innovation Center, Dong-Eui University)
Publication Information
Microbiology and Biotechnology Letters / v.43, no.4, 2015 , pp. 336-342 More about this Journal
Abstract
Previously, Euptelea pleiosperma was identified as one of the useful sources containing anti-oxidative and anti-inflammatory activities for the first time in our research group. In this study, anti-obesity effect of E. pleiosperma ethanol extract (EPEE) was evaluated by using a pancreatic lipase enzyme inhibition assay and a cell culture model system. EPEE suppressed effectively pancreatic lipase enzyme activity dose dependently. Furthermore, EPEE significantly suppressed adipocyte differentiation, lipid accumulation, triglyceride contents, and triggered lipolysis activity on 3T3-L1 preadipocytes in a dose-dependent manner without cytotoxicity. Anti-adipogenic effect of EPEE was modulated by cytidine-cytidine-adenosine-adenosine-thymidine (CCAAT)/enhancer binding proteins ${\alpha}(C/EBP{\alpha})$, $C/EBP{\beta}$ and peroxisome proliferator-activated receptor ${\gamma}(PPAR{\gamma})$ gene and protein expressions. Taken together, these results provide the important new insight that E. pleiosperma possesses anti-obesity activities such as pancreatic lipase inhibition, anti-adipogenic, and lipolysis effects. It might be utilized as promising sources in the fields of nutraceuticals. The identification of active compounds that confer anti-obesity activity of EPEE might be needed.
Keywords
Euptelea pleiosperma; anti-obesity activity; lipase inhibition activity; anti-adipogenic and lipolysis effects;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Chadt A, Scherneck S, Joost HG, Al-Hasani H. 2000. Molecular links between Obesity and Diabetes: "Diabesity".
2 de la Garza AL, Milagro FI, Boque N, Campion J, Martinez JA. 2011. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med. 77: 773-785.   DOI
3 Fock KM, Khoo J. 2013. Diet and exercise in management of obesity and overweight. J. Gastroenterol. Hepatol. 28(Suppl. 4): 59-63.   DOI
4 Guo L, Li X, Tang QQ. 2015. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) beta. J. Biol. Chem. 290: 755-761.   DOI
5 Haslam D. 2007. Obesity: a medical history. Obes. Rev. 8(Suppl. 1): 31-36.   DOI
6 Jin KS, Park JA, Lee JY, Kang JS, Kwon HJ, Kim BW. 2014. Anti-oxidative and anti-inflammatory activities of Euptelea pleiosperma ethanol extract. Korean J. Microbiol. Biotechnol. 42: 170-176.   DOI
7 Joo JK, Lee KS. 2014. Pharmacotherapy for obesity. J. Menopausal Med. 20: 90-96.   DOI
8 Kakkar AK, Dahiya N. 2015. Drug treatment of obesity: current status and future prospects. Eur. J. Int. Med. 26: 89-94.   DOI
9 Lane MD, Tang QQ, Jiang MS. 1999. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem. Biophys. Res. Commun. 266: 677-683.   DOI
10 Liu F, Kim J, Li Y, Liu X, Li J, Chen X. 2001. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr. 131: 2242-2247.   DOI
11 Ali AT, Hochfeld WE, Myburgh R, Pepper MS. 2013. Adipocyte and adipogenesis. Eur. J. Cell Biol. 92: 229-236.   DOI
12 Avram MM, Avram AS, James WD. 2007. Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J. Am. Acad. Dermatol. 56: 472-492.   DOI
13 Berry R, Jeffery E, Rodeheffer MS. 2014. Weighing in on adipocyte precursors. Cell Metab. 19: 8-20.   DOI
14 Bray GA. 2007. Medical therapy for obesity-current status and future hopes. Med. Clin. North Am. 91: 1225-1253.   DOI
15 Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5: 1538-1552.   DOI
16 Manulu MS, Sutanegara IN. 2006. Pathogenesis and pharmacologic treatment of obesity: the role of energy regulatory mechanism. Acta Med. Indones. 38: 42-50.
17 Ntambi JM, Young-Cheul K. 2000. Adipocyte differentiation and gene expression. J. Nutr. 130: 3122S-3126S.   DOI
18 Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16: 22-26.   DOI
19 Sorisky A. 1999. From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus. Crit. Rev. Clin. Lab. Sci. 36: 1-34.   DOI
20 World Health Organization 2015. Obesity and overweight. Fact sheet $N^{\circ}311$. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 28 August 2015.
21 Zhang WL, Zhu L, Jiang JG. 2014. Active ingredients from natural botanicals in the treatment of obesity. Obes. Rev. 15: 957-967.   DOI